COMBINATION CHEMOTHERAPY WITH OR WITHOUT HEXAMETHYLMELAMINE IN ALKYLATING-AGENT RESISTANT OVARIAN-CARCINOMA

被引：0
|
作者：
NEIJT, JP
HUININK, WWT
VANDERBURG, MEL
VANOOSTEROM, AT
KOOYMAN, CD
VANHOUWELINGEN, JC
PINEDO, HM
机构：
[1] CANC INST DANIEL DENHOEDT,DEPT ONCOL,ROTTERDAM,NETHERLANDS
[2] NETHERLANDS CANC INST,DEPT ONCOL,1066 CX AMSTERDAM,NETHERLANDS
[3] LEIDEN STATE UNIV HOSP,DEPT CLIN ONCOL,2333 AA LEIDEN,NETHERLANDS
[4] STATE UNIV UTRECHT HOSP,DEPT PATHOL,UTRECHT,NETHERLANDS
[5] STATE UNIV UTRECHT,DEPT STAT,UTRECHT,NETHERLANDS
[6] FREE UNIV AMSTERDAM HOSP,AMSTERDAM,NETHERLANDS
来源：
CANCER | 1984年 / 53卷 / 07期
关键词：
D O I：
10.1002/1097-0142(19840401)53:7<1467::AID-CNCR2820530707>3.0.CO;2-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1467 / 1472
页数：6
相关论文
共 50 条
  • [21] COMBINATION CHEMOTHERAPY AND IMMUNE CAPACITY IN ADVANCED OVARIAN-CARCINOMA
    TENBERGE, RJM
    SCHELLEKENS, PTA
    HAMERLYNCK, JVTH
    BRUNING, PF
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (01): : 91 - 98
  • [22] CHEMOTHERAPY IN OVARIAN-CARCINOMA
    LUND, B
    HANSEN, HH
    CANCER SURVEYS, 1989, 8 (03) : 681 - 691
  • [23] HEXAMETHYLMELAMINE AND MELPHALAN AS SALVAGE THERAPY IN ADVANCED OVARIAN-CARCINOMA
    TEMPERO, MA
    KESSINGER, A
    JOURNAL OF SURGICAL ONCOLOGY, 1982, 21 (03) : 159 - 161
  • [24] FAILURE OF HEXAMETHYLMELAMINE AS SALVAGE THERAPY IN OVARIAN EPITHELIAL ADENOCARCINOMA RESISTANT TO COMBINATION CHEMOTHERAPY
    STEHMAN, FB
    EHRLICH, CE
    CALLANGAN, MF
    GYNECOLOGIC ONCOLOGY, 1984, 17 (02) : 189 - 195
  • [25] OVARIAN-CANCER - EFFECTIVE TREATMENT AFTER ALKYLATING-AGENT FAILURE
    VOGL, SE
    GREENWALD, E
    KAPLAN, BH
    MOUKHTAR, M
    WOLLNER, D
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 241 (18): : 1908 - 1911
  • [26] PHASE-II TRIAL OF HEXAMETHYLMELAMINE (HMM) IN OVARIAN CARCINOMA AFTER ALKYLATING AGENT FAILURE
    BONOMI, P
    MORRIN, B
    WILBANKS, G
    SLAYTON, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 335 - 335
  • [27] PROSPECTIVE CONTROLLED RANDOMIZED TRIAL COMPARING COMBINATION CHEMOTHERAPY OF ADVANCED OVARIAN-CARCINOMA WITH ADRIAMYCIN AND CIS-PLATINUM+/- CYCLOPHOSPHAMIDE AND HEXAMETHYLMELAMINE
    BRUCKNER, HW
    COHEN, CJ
    WALLACH, RC
    KABAKOW, B
    DEPPE, G
    GREENSPAN, EM
    GUSBERG, SB
    HOLLAND, JF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 414 - 414
  • [28] PHASE-II TRIAL OF CYCLOPHOSPHAMIDE, HEXAMETHYLMELAMINE, ADRIAMYCIN, AND CIS-DICHLORODIAMMINEPLATINUM(II) COMBINATION CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA
    KANE, R
    HARVEY, H
    ANDREWS, T
    BERNATH, A
    CURRY, S
    DIXON, R
    GOTTLIEB, R
    KUKRIKA, M
    LIPTON, A
    MORTEL, R
    RICCI, J
    WHITE, D
    CANCER TREATMENT REPORTS, 1979, 63 (02): : 307 - 309
  • [29] ACUTE-LEUKEMIA AFTER ALKYLATING-AGENT THERAPY OF OVARIAN CANCER
    REIMER, RR
    HOOVER, R
    FRAUMENI, JF
    YOUNG, RC
    NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (04): : 177 - 181
  • [30] COMBINATION ANTIMETABOLITE AND ALKYLATING AGENT CHEMOTHERAPY IN ADVANCED BREAST CARCINOMA
    GREENSPAN, EM
    NEW YORK STATE JOURNAL OF MEDICINE, 1968, 68 (06) : 780 - +
12345